Literature DB >> 23928395

Preeclampsia: an obstetrician's perspective.

Mary L Rosser1, Nadine T Katz.   

Abstract

Preeclampsia is a pregnancy-specific syndrome that usually develops after 20 weeks gestation. The exact pathogenic mechanisms remain uncertain and are likely multifactorial. Preeclampsia is a heterogeneous condition with potentially maternal and fetal consequences. As part of the spectrum of hypertensive disorders of pregnancy, preeclampsia may progress rapidly and is a leading cause of maternal and perinatal morbidity and mortality worldwide. In the United States, the incidence of preeclampsia has increased. Clinical manifestations are highly variable and may occur antepartum, intrapartum, or postpartum. Hypertension and proteinuria are the traditional hallmarks for the diagnosis of preeclampsia. These signs may occur with or without multisystem dysfunction and fetal involvement. Risk factors have been identified for the development of preeclampsia; however, ideal methods for prevention, screening, and treatment remain elusive. Preeclampsia resolves after delivery of the fetus, but patients may still have hypertension postpartum. Women and fetuses affected by preeclampsia are at higher risk of developing long-term health issues. There appear to be risk factors common to hypertensive disorders of pregnancy and cardiovascular disease seen later in adulthood. Physicians providing healthcare to women are urged to recognize potential risk factors that arise from patient obstetric histories so that optimal long-term health surveillance is provided.
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23928395     DOI: 10.1053/j.ackd.2013.02.005

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  14 in total

Review 1.  Monitoring fetal maturation-objectives, techniques and indices of autonomic function.

Authors:  Dirk Hoyer; Jan Żebrowski; Dirk Cysarz; Hernâni Gonçalves; Adelina Pytlik; Célia Amorim-Costa; João Bernardes; Diogo Ayres-de-Campos; Otto W Witte; Ekkehard Schleußner; Lisa Stroux; Christopher Redman; Antoniya Georgieva; Stephen Payne; Gari Clifford; Maria G Signorini; Giovanni Magenes; Fernando Andreotti; Hagen Malberg; Sebastian Zaunseder; Igor Lakhno; Uwe Schneider
Journal:  Physiol Meas       Date:  2017-02-10       Impact factor: 2.833

2.  Prolonged uterine artery nitric oxide synthase inhibition modestly alters basal uteroplacental vasodilation in the last third of ovine pregnancy.

Authors:  Charles R Rosenfeld; Timothy Roy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

3.  Early pregnancy waist-to-hip ratio and risk of preeclampsia: a prospective cohort study.

Authors:  Mahboubeh Taebi; Zohreh Sadat; Farzaneh Saberi; Masoumeh Abedzadeh Kalahroudi
Journal:  Hypertens Res       Date:  2014-09-04       Impact factor: 3.872

4.  MicroRNA-135b-5p regulates trophoblast cell function by targeting phosphoinositide-3-kinase regulatory subunit 2 in preeclampsia.

Authors:  Xia Zhang; Xiufeng Zhang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 5.  Proteinuria in preeclampsia from a podocyte injury perspective.

Authors:  Daniel E Henao; Moin A Saleem
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

6.  Posterior reversible encephalopathy syndrome (PRES) in a patient with late postpartum eclampsia.

Authors:  Jharendra P Rijal; Smith Giri; Suvash Dawadi; Khagendra V Dahal
Journal:  BMJ Case Rep       Date:  2014-02-27

7.  Retinol-binding protein 4 regulates the biological functions and molecular mechanisms of JEG-3 cells.

Authors:  Fuchan Wang; Guangming Cao; Qing Liu; Xiulan Li; Meiying Song; Zhenyu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

Review 8.  Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia.

Authors:  Felipe A Zuniga; Valeska Ormazabal; Nicolas Gutierrez; Valeria Aguilera; Claudia Radojkovic; Carlos Veas; Carlos Escudero; Liliana Lamperti; Claudio Aguayo
Journal:  Biomed Res Int       Date:  2014-07-06       Impact factor: 3.411

9.  Pre-Pregnancy BMI, Gestational Weight Gain, and the Risk of Hypertensive Disorders of Pregnancy: A Cohort Study in Wuhan, China.

Authors:  Aifen Zhou; Chao Xiong; Ronghua Hu; Yiming Zhang; Bryan A Bassig; Elizabeth Triche; Shaoping Yang; Lin Qiu; Yaqi Zhang; Cong Yao; Shunqing Xu; Youjie Wang; Wei Xia; Zhengmin Qian; Tongzhang Zheng; Bin Zhang
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

10.  The Use of Fetal Noninvasive Electrocardiography.

Authors:  Igor Lakhno
Journal:  Scientifica (Cairo)       Date:  2016-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.